EPO Patents = 4

Forward Citations = 7

Loading Chart...

10 inventors (with patents filed for the assignee):

Shelley Erin Ackerman (6 out of 6 patents)

Justin A Kenkel (5 out of 5 patents)

Edgar George Engleman (4 out of 42 patents)

4. Arthur Lee (4 out of 19 patents)

5. David Y Jackson (4 out of 18 patents)

6. Michael Nathaniel Alonso (4 out of 4 patents)

7. Karla Ann Henning (2 out of 22 patents)

8. David Dornan (2 out of 2 patents)

9. Brian Salvatore Safina (1 out of 46 patents)

10. Romas Kudirka (1 out of 1 patent)

11. Richard P Laura (0 patent)

7 patents: Sort by Forward Citations

1. 12325750 - Anti-Dectin-2 antibodies and methods of using (2025-06-10),

2. 11753474 - Anti-Dectin-2 antibodies (2023-09-12),

3. 11654199 - Thienoazepine immunoconjugates, and uses thereof (2023-05-23),

4. 11547761 - Antibody adjuvant conjugates (2023-01-10),

5. 11400164 - Immunoconjugates targeting HER2 (2022-08-02),

6. 11110178 - Antibody adjuvant conjugates (2021-09-07),

7. 10675358 - Antibody adjuvant conjugates (2020-06-09),

Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company pioneering a new class of cancer therapeutics known as Immune-stimulating Antibody Conjugates (ISACs). The company's lead candidate, BDC-1001, is in clinical development for the treatment of solid tumors. Bolt Biotherapeutics aims to harness the power of the immune system to fight cancer and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#186 in Redwood City, CA

#9,216 in California

#38,834 in US

Redwood City, CA, United States of America

Bolt Biotherapeutics, Inc.